Literature DB >> 33574586

FDA approves fourth CAR-T cell therapy.

Asher Mullard.   

Abstract

Entities:  

Year:  2021        PMID： 33574586     DOI： 10.1038/d41573-021-00031-9

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  26 in total

Review 1.  Cellular kinetics: A clinical and computational review of CAR-T cell pharmacology.

Authors:  Timothy Qi; Kyle McGrath; Raghuveer Ranganathan; Gianpietro Dotti; Yanguang Cao
Journal:  Adv Drug Deliv Rev       Date:  2022-07-06       Impact factor: 17.873

Review 2.  Transcriptional determinants of cancer immunotherapy response and resistance.

Authors:  Romi Gupta; Amitkumar Mehta; Narendra Wajapeyee
Journal:  Trends Cancer       Date:  2022-02-03

3.  Spermidine Promotes Nb CAR-T Mediated Cytotoxicity to Lymphoma Cells Through Elevating Proliferation and Memory.

Authors:  Hongxia Wang; Dan Jiang; Liyuan Liu; Yanting Zhang; Miao Qin; Yuliang Qu; Liyan Wang; Shan Wu; Haijin Zhou; Tao Xu; Guangxian Xu
Journal:  Onco Targets Ther       Date:  2022-10-18       Impact factor: 4.345

Review 4.  CAR T-cell therapy for pleural mesothelioma: Rationale, preclinical development, and clinical trials.

Authors:  Navin K Chintala; David Restle; Hue Quach; Jasmeen Saini; Rebecca Bellis; Michael Offin; Jason Beattie; Prasad S Adusumilli
Journal:  Lung Cancer       Date:  2021-05-05       Impact factor: 6.081

Review 5.  In Like a Lamb; Out Like a Lion: Marching CAR T Cells Toward Enhanced Efficacy in B-ALL.

Authors:  Pouya Safarzadeh Kozani; Pooria Safarzadeh Kozani; Roddy S O'Connor
Journal:  Mol Cancer Ther       Date:  2021-04-26       Impact factor: 6.009

Review 6.  Strategies for Dodging the Obstacles in CAR T Cell Therapy.

Authors:  Pooria Safarzadeh Kozani; Pouya Safarzadeh Kozani; Fatemeh Rahbarizadeh; Shahryar Khoshtinat Nikkhoi
Journal:  Front Oncol       Date:  2021-04-01       Impact factor: 6.244

Review 7.  Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based Therapies.

Authors:  Ponthip Pratumkaew; Surapol Issaragrisil; Sudjit Luanpitpong
Journal:  Cells       Date:  2021-11-19       Impact factor: 6.600

Review 8.  Extracellular Vesicles as an Advanced Delivery Biomaterial for Precision Cancer Immunotherapy.

Authors:  Shaobo Ruan; Zachary Greenberg; Xiaoshu Pan; Pei Zhuang; Nina Erwin; Mei He
Journal:  Adv Healthc Mater       Date:  2021-07-01       Impact factor: 11.092

Review 9.  Current Limitations and Perspectives of Chimeric Antigen Receptor-T-Cells in Acute Myeloid Leukemia.

Authors:  Marius Maucher; Micha Srour; Sophia Danhof; Hermann Einsele; Michael Hudecek; Ibrahim Yakoub-Agha
Journal:  Cancers (Basel)       Date:  2021-12-07       Impact factor: 6.639

Review 10.  Shaping Immune Responses in the Tumor Microenvironment of Ovarian Cancer.

Authors:  Xin Luo; Jing Xu; Jianhua Yu; Ping Yi
Journal:  Front Immunol       Date:  2021-06-23       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.